Jinhe Biotechnology CO., LTD. (SHE:002688)
China · Delayed Price · Currency is CNY 5.02
+0.02 (0.40%)
Jul 30, 2026, 3:04 PM CST
SHE:002688 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,778 | 4,475 | 3,381 | 3,626 | 3,874 | 4,784 | |
Market Cap Growth | -29.74% | 32.34% | -6.73% | -6.42% | -19.02% | 37.17% |
Enterprise Value | 5,892 | 6,516 | 5,247 | 5,513 | 4,955 | 5,371 |
Last Close Price | 5.00 | 5.84 | 4.32 | 4.55 | 4.76 | 5.68 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 100.66 | 162.40 | 33.75 | 41.94 | 51.24 | 50.90 |
Forward PE | - | 22.04 | 19.91 | 21.86 | 15.10 | 15.72 |
PS Ratio | 1.26 | 1.56 | 1.43 | 1.67 | 1.83 | 2.30 |
PB Ratio | 1.51 | 1.83 | 1.35 | 1.44 | 1.60 | 1.77 |
P/TBV Ratio | 2.72 | 3.40 | 2.95 | 3.32 | 3.00 | 3.20 |
P/FCF Ratio | 40.18 | 30.11 | 24.83 | - | - | - |
P/OCF Ratio | 8.79 | 9.54 | 6.78 | 18.24 | 31.13 | 31.27 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 1.97 | 2.26 | 2.21 | 2.54 | 2.33 | 2.59 |
EV/EBITDA Ratio | 10.27 | 12.32 | 13.21 | 17.16 | 17.55 | 16.08 |
EV/EBIT Ratio | 18.20 | 21.79 | 24.77 | 37.14 | 37.22 | 26.46 |
EV/FCF Ratio | 62.65 | 43.83 | 38.53 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 1.10 | 0.99 | 0.98 | 0.91 | 0.66 | 0.37 |
Debt / EBITDA Ratio | 4.78 | 4.50 | 6.05 | 7.02 | 5.54 | 3.01 |
Debt / FCF Ratio | 29.12 | 16.27 | 18.02 | - | - | - |
Net Debt / Equity Ratio | 0.76 | 0.74 | 0.73 | 0.67 | 0.46 | 0.18 |
Net Debt / EBITDA Ratio | 3.37 | 3.40 | 4.57 | 5.26 | 3.93 | 1.47 |
Net Debt / FCF Ratio | 20.20 | 12.10 | 13.35 | -6.54 | -4.00 | -2.12 |
Asset Turnover | 0.52 | 0.52 | 0.43 | 0.44 | 0.50 | 0.56 |
Inventory Turnover | 2.90 | 2.98 | 2.51 | 2.33 | 2.47 | 2.87 |
Quick Ratio | 0.86 | 0.73 | 0.71 | 0.58 | 0.61 | 0.88 |
Current Ratio | 1.30 | 1.14 | 1.09 | 0.90 | 1.05 | 1.42 |
Return on Equity (ROE) | 0.02% | -0.44% | 3.36% | 3.82% | 4.61% | 5.49% |
Return on Assets (ROA) | 3.52% | 3.35% | 2.38% | 1.86% | 1.94% | 3.41% |
Return on Invested Capital (ROIC) | 0.08% | -1.96% | 4.29% | 3.57% | 3.94% | 5.82% |
Return on Capital Employed (ROCE) | 8.20% | 8.00% | 5.60% | 4.60% | 4.70% | 7.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 1.03% | 0.62% | 2.96% | 2.38% | 1.95% | 1.97% |
FCF Yield | 2.49% | 3.32% | 4.03% | -7.13% | -7.17% | -4.82% |
Dividend Yield | 2.02% | 1.71% | 2.31% | 2.20% | 2.10% | - |
Payout Ratio | 375.89% | 536.52% | 160.64% | 171.99% | 53.63% | 111.00% |
Buyback Yield / Dilution | -1.00% | -0.81% | 0.76% | 0.01% | -12.16% | -6.74% |
Total Shareholder Return | 1.04% | 0.90% | 3.08% | 2.21% | -10.06% | -6.74% |